Landriscina M - Search Results

1

Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.

Landriscina M, Amoroso MR, Piscazzi A, Esposito F. Landriscina M, et al. Gynecol Oncol. 2010 May;117(2):177-82. doi: 10.1016/j.ygyno.2009.10.078. Epub 2009 Nov 25. Gynecol Oncol. 2010. PMID: 19942270 Review.

2

Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma.

Landriscina M, Fabiano A, Altamura S, Bagalà C, Piscazzi A, Cassano A, Spadafora C, Giorgino F, Barone C, Cignarelli M. Landriscina M, et al. J Clin Endocrinol Metab. 2005 Oct;90(10):5663-71. doi: 10.1210/jc.2005-0367. Epub 2005 Jul 19. J Clin Endocrinol Metab. 2005. PMID: 16030158

3

S100A13, a new marker of angiogenesis in human astrocytic gliomas.

Landriscina M, Schinzari G, Di Leonardo G, Quirino M, Cassano A, D'Argento E, Lauriola L, Scerrati M, Prudovsky I, Barone C. Landriscina M, et al. J Neurooncol. 2006 Dec;80(3):251-9. doi: 10.1007/s11060-006-9189-y. Epub 2006 Jun 14. J Neurooncol. 2006. PMID: 16773219

4

Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis.

Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F. Montesano Gesualdi N, et al. Among authors: landriscina m. Stress. 2007 Nov;10(4):342-50. doi: 10.1080/10253890701314863. Stress. 2007. PMID: 17853063

5

Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma.

Landriscina M, Altamura SA, Roca L, Gigante M, Piscazzi A, Cavalcanti E, Costantino E, Barone C, Cignarelli M, Gesualdo L, Ranieri E. Landriscina M, et al. Int J Cancer. 2008 Jun 15;122(12):2842-50. doi: 10.1002/ijc.23197. Int J Cancer. 2008. PMID: 18351578 Free article.

6

Nevirapine toxicity in non-HIV cancer patients.

Landriscina M, Fabiano A, Lombardi V, Santodirocco M, Piscazzi A, Fersini A, De Vis K, Barone C, Cignarelli M. Landriscina M, et al. Chemotherapy. 2008;54(6):475-8. doi: 10.1159/000159273. Epub 2008 Oct 2. Chemotherapy. 2008. PMID: 18832820 Clinical Trial.

7

Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.

Landriscina M, Bagalà C, Piscazzi A, Schinzari G, Quirino M, Fabiano A, Bianchetti S, Cassano A, Sica G, Barone C. Landriscina M, et al. Prostate. 2009 May 15;69(7):744-54. doi: 10.1002/pros.20923. Prostate. 2009. PMID: 19152342

8

TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.

Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, Ambrosi A, Neri V, Esposito F, Landriscina M. Costantino E, et al. Among authors: landriscina m. Cancer Lett. 2009 Jun 28;279(1):39-46. doi: 10.1016/j.canlet.2009.01.018. Epub 2009 Feb 12. Cancer Lett. 2009. PMID: 19217207

9

Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.

Landriscina M, Piscazzi A, Fabiano A, Maddalena F, Costantino E, Farese A, Bufo P, Cignarelli M. Landriscina M, et al. Thyroid. 2009 Jun;19(6):629-37. doi: 10.1089/thy.2008.0355. Thyroid. 2009. PMID: 19499990

10

Adaptation to oxidative stress, chemoresistance, and cell survival.

Landriscina M, Maddalena F, Laudiero G, Esposito F. Landriscina M, et al. Antioxid Redox Signal. 2009 Nov;11(11):2701-16. doi: 10.1089/ars.2009.2692. Antioxid Redox Signal. 2009. PMID: 19778285 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page